Hepatitis research and treatment最新文献_第2页

Prevalence of Hepatitis E Virus among Adults in South-West of Iran. 伊朗西南部成人戊型肝炎病毒流行情况

Hepatitis research and treatment Pub Date : 2015-01-01 Epub Date: 2015-06-23 DOI: 10.1155/2015/759589

Fatemeh Farshadpour, Reza Taherkhani, Manoochehr Makvandi

{"title":"Prevalence of Hepatitis E Virus among Adults in South-West of Iran.","authors":"Fatemeh Farshadpour, Reza Taherkhani, Manoochehr Makvandi","doi":"10.1155/2015/759589","DOIUrl":"https://doi.org/10.1155/2015/759589","url":null,"abstract":"Background. Knowledge regarding prevalence of HEV in general population can be an indicator of the public health and hygiene. Therefore, this study was conducted to evaluate the prevalence of HEV among adults in South-West of Iran. Methods. Blood samples were taken from 510 participants, 206 (40.4%) males and 304 (59.6%) females from February to July 2014. Detection of anti-HEV IgG and IgM antibodies was carried out by ELISA test. Results. The overall anti-HEV IgG and IgM prevalence rates were 46.1% and 1.4%, respectively. Anti-HEV IgG and IgM seropositivity were not statistically associated with gender and race/ethnicity. Meanwhile, there were significant differences between the age groups regarding HEV IgG and IgM seropositivity. HEV IgG seroprevalence increased with age from 14.3% in subjects aged 18-30 years to 71.4% in persons over 71 years old, and considerably individuals aged 61 to 70 years had the highest HEV prevalence (90.9%). Also, 5.7% in the age group 18-30 years and 2.2% in the age group 31-40 years were positive for anti-HEV IgM antibodies and the highest rate was observed in subjects aged 18-30 years. Conclusion. In conclusion, high HEV IgG seroprevalence of 46.1% was observed among adults in South-West of Iran. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2015 ","pages":"759589"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33859189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 35

Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary Hospital. 尼日利亚一家三级医院医护人员对乙型肝炎病毒感染、乙型肝炎疫苗免疫、风险认知和控制肝炎的挑战的了解

Hepatitis research and treatment Pub Date : 2015-01-01 Epub Date: 2015-01-22 DOI: 10.1155/2015/439867

Olusegun Adekanle, Dennis A Ndububa, Samuel Anu Olowookere, Oluwasegun Ijarotimi, Kayode Thaddeus Ijadunola

{"title":"Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary Hospital.","authors":"Olusegun Adekanle, Dennis A Ndububa, Samuel Anu Olowookere, Oluwasegun Ijarotimi, Kayode Thaddeus Ijadunola","doi":"10.1155/2015/439867","DOIUrl":"https://doi.org/10.1155/2015/439867","url":null,"abstract":"Background. Studies had reported high rate of hepatitis B infection among hospital workers with low participation in vaccination programmes, especially those whose work exposes them to the risk of HBV infection. The study assessed knowledge of hepatitis B virus infection, risk perception, vaccination history, and challenges to control hepatitis among health workers. Methods. A descriptive cross-sectional study. Consenting health care workers completed a self-administered questionnaire that assessed respondents' general knowledge of HBV, vaccination history and HBsAg status, risk perception, and challenges to control hepatitis. Data was analysed using descriptive and inferential statistics. Results. Three hundred and eighty-two health care workers participated in the study. There were 182 males and 200 females. The respondents comprised 94 (25%) medical doctors, 168 (44%) nurses, 68 (18%) medical laboratory technologists, and 52 (14%) pharmacists. Over 33% had poor knowledge with 35% not immunized against HBV. Predictors of good knowledge include age less than 35 years, male sex, being a medical doctor, previous HBsAg test, and complete HBV immunisation. Identified challenges to control hepatitis include lack of hospital policy (91.6%), poor orientation of newly employed health workers (75.9%), and low risk perception (74.6%). Conclusion. Hospital policy issues and low risk perception of HBV transmission have grave implications for the control of HBV infection. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2015 ","pages":"439867"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/439867","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33057225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 84

Prevalence of hepatitis C virus genotypes in district bannu, khyber pakhtunkhwa, pakistan. 巴基斯坦开伯尔-普赫图赫瓦省班努县丙型肝炎病毒基因型流行情况

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-06-30 DOI: 10.1155/2014/165826

Shamim Saleha, Anwar Kamal, Farman Ullah, Nasar Khan, Asif Mahmood, Sanaullah Khan

{"title":"Prevalence of hepatitis C virus genotypes in district bannu, khyber pakhtunkhwa, pakistan.","authors":"Shamim Saleha, Anwar Kamal, Farman Ullah, Nasar Khan, Asif Mahmood, Sanaullah Khan","doi":"10.1155/2014/165826","DOIUrl":"https://doi.org/10.1155/2014/165826","url":null,"abstract":"Determination of an individual's hepatitis C virus (HCV) genotypes prior to antiviral therapy has become increasingly important for the clinical management and prognosis of HCV infection. Therefore, this study was conducted to investigate the prevalence of HCV genotypes in HCV infected patients of district Bannu in Khyber Pakhtunkhwa region of Pakistan. Serum samples of 117 seropositive patients were screened for HCV-RNA by using reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) and then PCR positive samples were subjected to HCV genotyping. Out of 117 seropositive samples, 110 samples were found positive by PCR analysis. Genotype 3a was the most prevalent one detected in 38% of patients, followed by genotype 3b in 21% of patients, and then genotype 2a in 12% of patients. However 21% of HCV-PCR positive samples could not be genotyped by method used in this study. Genotype 3a was the most prevalent genotype in patients of all age groups and its prevalence was found high among patients with increasing age (>34 years). Moreover, genotypes 3a and 3b were found to be the most prevalent genotypes in patients with history of shaving by barbers, receiving multiple injections, and dental procedures. In conclusion there is need of further investigation of genotypes of HCV by using more sensitive assays and considering large sample size in district Bannu. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"165826"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/165826","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32561391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 20

Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levels. 丙氨酸转氨酶持续正常的慢性丙型肝炎患者的组织学和临床特征。

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-05-07 DOI: 10.1155/2014/760943

Bakht Roshan, Grace Guzman

{"title":"Histological and clinical characteristics of patients with chronic hepatitis C and persistently normal alanine aminotransferase levels.","authors":"Bakht Roshan, Grace Guzman","doi":"10.1155/2014/760943","DOIUrl":"https://doi.org/10.1155/2014/760943","url":null,"abstract":"Patients with chronic hepatitis C virus (HCV) infection and persistently normal alanine aminotransferase (PNALT) are generally described to have mild liver disease. The aim of this study was to compare clinical and histological features in HCV-infected patients with PNALT and elevated ALT. Patients presenting to the University of Illinois Medical Center, Chicago, who had biopsy proven HCV, an ALT measurement at the time of liver biopsy, at least one additional ALT measurement over the next 12 months, and liver biopsy slides available for review were identified. PNALT was defined as ALT ≤ 30 on at least 2 different occasions over 12 months. Of 1200 patients with HCV, 243 met the study criteria. 13% (32/243) of patients had PNALT while 87% (211/243) had elevated ALT. Significantly more patients with PNALT had advanced fibrosis (F3 and F4) compared to those with elevated ALT (P = 0.007). There was no significant difference in the histology activity index score as well as mean inflammatory score between the two groups. In conclusion, in a well-characterized cohort of patients at a tertiary medical center, PNALT did not distinguish patients with mild liver disease. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"760943"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/760943","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32394132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso. 布基纳法索普通人群乙型和丙型肝炎病毒的血清流行病学。

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-08-05 DOI: 10.1155/2014/781843

Issoufou Tao, Tegwindé R Compaoré, Birama Diarra, Florencia Djigma, Theodora M Zohoncon, Maléki Assih, Djeneba Ouermi, Virginio Pietra, Simplice D Karou, Jacques Simpore

{"title":"Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso.","authors":"Issoufou Tao, Tegwindé R Compaoré, Birama Diarra, Florencia Djigma, Theodora M Zohoncon, Maléki Assih, Djeneba Ouermi, Virginio Pietra, Simplice D Karou, Jacques Simpore","doi":"10.1155/2014/781843","DOIUrl":"https://doi.org/10.1155/2014/781843","url":null,"abstract":"Objectives. In Burkina Faso, few studies reported the prevalence of HBV and HCV in the general population. This study aimed to evaluate the prevalence of hepatitis B and C viruses in the general population and to determine the most affected groups in relation to the risk factors associated with the infection. Method. A voluntary testing opened to anyone interested was held at Saint Camille Medical Centre in Ouagadougou. Rapid tests were carried out on 995 persons who voluntarily answered a range of questions before the venous blood sampling. Results. The results revealed that the antigen HBs carriers in the general population represented 14.47% (144/995) and the prevalence of HCV was 1.00% (10/995). The difference between HBV's prevalence in men (18.58%) and that in women (11.60%) was statistically significant (P = 0.002). The most affected groups were undergraduated students (19.57%) and persons working in the informal sector (15.98%). The least affected group was high level students (8.82%). Conclusion. Burkina Faso is a country with a high prevalence of HBV, while the incidence of HCV is still low in the general population. Therefore, more campaigns on the transmission routes of HBV and HCV are needed to reduce the spread of these viruses in sub-Saharan Africa. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"781843"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/781843","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32617668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 54

High dose of Lamivudine and resistance in patients with chronic hepatitis B. 慢性乙型肝炎患者的大剂量拉米夫定和耐药性。

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-09-30 DOI: 10.1155/2014/615621

Hamid Ullah Wani, Saad Al Kaabi, Manik Sharma, Rajvir Singh, Anil John, Moutaz Derbala, Muneera J Al-Mohannadi

{"title":"High dose of Lamivudine and resistance in patients with chronic hepatitis B.","authors":"Hamid Ullah Wani, Saad Al Kaabi, Manik Sharma, Rajvir Singh, Anil John, Moutaz Derbala, Muneera J Al-Mohannadi","doi":"10.1155/2014/615621","DOIUrl":"https://doi.org/10.1155/2014/615621","url":null,"abstract":"Background. Lamivudine is the most affordable drug used for chronic hepatitis B and has a high safety profile. With the daily dose of 100 mg there is progressive appearance of resistance to lamivudine therapy. In our study we used 150 mg of lamivudine daily as a standard dose which warrants further exploration for the efficacy of the drug. Aims of the Study. To assess the efficacy of lamivudine 150 mg daily on resistance in patients with chronic hepatitis B. Methods. This retrospective study consists of 53 patients with chronic hepatitis B treated with 150 mg of lamivudine daily. The biochemical and virological response to the treatment were recorded at a 1-year and 2-, 3-, 4-, and 5-year period and time of emergence of resistance to the treatment was noted. Results. The mean age of the patients was 54 years with 80% being males. The resistance to lamivudine 150 mg daily at 1 year and 2, 3, and 5 years was 12.5%, 22.5%, 37.5%, and 60%, respectively, which is much less compared to the standard dose of 100 mg of lamivudine. Conclusions. Lamivudine is safe and a higher dose of 150 mg daily delays the resistance in patients with chronic hepatitis B. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"615621"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/615621","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32775712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection. MHC I类提出T细胞表位作为抗HBV慢性感染治疗性疫苗的潜在抗原

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-05-26 DOI: 10.1155/2014/860562

Joseph D Comber, Aykan Karabudak, Vivekananda Shetty, James S Testa, Xiaofang Huang, Ramila Philip

{"title":"MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection.","authors":"Joseph D Comber, Aykan Karabudak, Vivekananda Shetty, James S Testa, Xiaofang Huang, Ramila Philip","doi":"10.1155/2014/860562","DOIUrl":"https://doi.org/10.1155/2014/860562","url":null,"abstract":"Approximately 370 million people worldwide are chronically infected with hepatitis B virus (HBV). Despite the success of the prophylactic HBV vaccine, no therapeutic vaccine or other immunotherapy modality is available for treatment of chronically infected individuals. Clearance of HBV depends on robust, sustained CD8(+) T activity; however, the limited numbers of therapeutic vaccines tested have not induced such a response. Most of these vaccines have relied on peptide prediction algorithms to identify MHC-I epitopes or characterization of T cell responses during acute infection. Here, we took an immunoproteomic approach to characterize MHC-I restricted epitopes from cells chronically infected with HBV and therefore more likely to represent the true targets of CD8(+) T cells during chronic infection. In this study, we identified eight novel MHC-I restricted epitopes derived from a broad range of HBV proteins that were capable of activating CD8(+) T cells. Furthermore, five of the eight epitopes were able to bind HLA-A2 and A24 alleles and activated HBV specific T cell responses. These epitopes also have potential as new tools to characterize T cell immunity in chronic HBV infection and may serve as candidate antigens for a therapeutic vaccine against HBV infection. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"860562"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/860562","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32459667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 21

Interleukin-16 gene polymorphisms are considerable host genetic factors for patients' susceptibility to chronic hepatitis B infection. 白细胞介素-16基因多态性是慢性乙型肝炎易感性的重要宿主遗传因素。

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-11-26 DOI: 10.1155/2014/790753

Sara Romani, Seyed Masoud Hosseini, Seyed Reza Mohebbi, Shabnam Kazemian, Shaghayegh Derakhshani, Mahsa Khanyaghma, Pedram Azimzadeh, Afsaneh Sharifian, Mohammad Reza Zali

{"title":"Interleukin-16 gene polymorphisms are considerable host genetic factors for patients' susceptibility to chronic hepatitis B infection.","authors":"Sara Romani, Seyed Masoud Hosseini, Seyed Reza Mohebbi, Shabnam Kazemian, Shaghayegh Derakhshani, Mahsa Khanyaghma, Pedram Azimzadeh, Afsaneh Sharifian, Mohammad Reza Zali","doi":"10.1155/2014/790753","DOIUrl":"https://doi.org/10.1155/2014/790753","url":null,"abstract":"Host genetic background is known as an important factor in patients' susceptibility to infectious diseases such as viral hepatitis. The aim of this study was to determine the effect of genetic polymorphisms of interleukin-16 (IL-16) cytokine on susceptibility of hepatitis B virus (HBV) infected patients to develop chronic HBV infection. Genotyping was conducted using PCR followed by enzymatic digestion and RFLP (restriction fragment length polymorphism) analysis. We genotyped three single nucleotide polymorphisms (SNPs) in the Il-16 gene (rs11556218 T>G, rs4778889 T>C, and rs4072111 C>T) to test for relationship between variation at these loci and patients' susceptibility to chronic HBV infection. Allele frequency of Il-16 gene rs4072111 and rs11556218 was significantly different between chronic HBV patients and healthy blood donors. Genotype frequency of rs4778889 polymorphism of Il-16 gene was significantly different when chronic HBV patients and HBV clearance subjects were compared. Our results showed that Il-16 gene polymorphisms are considerable host genetic factors when we chase biomarkers for prognosis of HBV infected patients. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"790753"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/790753","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33393834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 29

Hepatitis B vaccination and screening awareness in primary care practitioners. 初级保健从业人员的乙肝疫苗接种和筛查意识。

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-03-06 DOI: 10.1155/2014/373212

Adnan Said, Janice H Jou

{"title":"Hepatitis B vaccination and screening awareness in primary care practitioners.","authors":"Adnan Said, Janice H Jou","doi":"10.1155/2014/373212","DOIUrl":"https://doi.org/10.1155/2014/373212","url":null,"abstract":"Introduction. The goals of Healthy People US 2020 have called for increased screening and vaccination of high-risk groups for Hepatitis B (HBV). Methods. We performed a survey of 400 randomly chosen primary care practitioners (PCPs) in Wisconsin to assess their knowledge, attitudes, and practices regarding screening and vaccination for HBV. Results. Screening rates of patients at risk of sexual transmission were low, with 61% of respondents stating that they screen patients who had more than 1 sex partner in 6 months and 86% screening patients with a history of sex with prostitutes. Screening rate for persons with a history of intravenous drug use was 94%. Children of immigrants were screened by 65%, persons on hemodialysis by 73%, and prison inmates by 69%. Screening increased with provider experience with HBV. Deficiencies in vaccination rates mirrored screening practices. Major barriers to screening were cost, someone else's responsibility, time constraints, or lack of knowledge. Conclusions. Without improved education and practices of PCPs about HBV screening and vaccination, the goals of healthy people 2020 regarding HBV will not be met. Barriers to screening and vaccination need to be addressed. Cost-effectiveness of alternative strategies such as universal vaccination under the age of 50 should be explored. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"373212"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/373212","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32261667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University. 叙利亚私立大学医学生对乙型肝炎的认识及其疫苗接种状况

Hepatitis research and treatment Pub Date : 2014-01-01 Epub Date: 2014-11-12 DOI: 10.1155/2014/131920

Nazir Ibrahim, Amr Idris

{"title":"Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University.","authors":"Nazir Ibrahim, Amr Idris","doi":"10.1155/2014/131920","DOIUrl":"https://doi.org/10.1155/2014/131920","url":null,"abstract":"Background. Hepatitis B virus (HBV) is a potentially life-threating infection and a well-recognized occupational hazard for health-care workers including medical students. Methods. A cross-sectional study was conducted at Syrian Private University (SPU), Faculty of Medicine, to assess the knowledge and awareness about hepatitis B, the status of hepatitis B vaccination, and the reasons for not getting vaccinated among the first- and the fifth-year medical students. Results. The present study demonstrates surprising results and raises issues about the high number of medical students that are not vaccinated or not sure about their vaccination status, which puts them at a higher risk of being infected in the future. Another important issue is the medical students' overall knowledge about this life-threating infection. The students have not been totally educated about the gravity of the situation which requires the need of further HBV education. It is highly recommended that SPU provides the HBV vaccine to all nonvaccinated students attending the faculty of medicine at no cost to encourage them to take the HBV vaccine and to reform some of its educational curriculum to effectively limit the hazardous effects of this disease and elaborate on the serious health consequences of HBV. ","PeriodicalId":73232,"journal":{"name":"Hepatitis research and treatment","volume":"2014 ","pages":"131920"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/131920","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32882665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 61